Table 1.
Clinical characteristics of included studies with Xp11.2 tRCC
| Cases | LN metastasis | Distant metastases | Mean age | Main diagnostic method | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| male/C | female/C | male/A | female/A | male/C | female/C | male/A | female/A | male/C | female/C | male/A | female/A | ||||
| Levevte et al. [12] | 1 | 1 | 12 | 14 | 0/1 | 0/1 | 3/12 | 2/14 | 0/1 | 0/1 | 5/12 | 6/14 | – | FISH | |
| Chenchen et al. [13] | 0 | 0 | 7 | 9 | – | – | – | – | – | – | – | – | – | IHC + FISH | |
| Ning Liu et al. [14] | 2 | 2 | 11 | 19 | 0/2 | 0/2 | 1/11 | 4/19 | 0/2 | 0/2 | 1/11 | 2/19 | 44.5 ± 18.3 | FISH | |
| Argani et al. [15] | 0 | 0 | 6 | 22 | 0/0 | 0/0 | 2/6 | 9/22 | 0/0 | 0/0 | 2/6 | 2/22 | 37 ± 16.6 | IHC + FISH | |
| Green et al. [16] | 0 | 2 | 10 | 19 | 0/0 | 2/2 | 0/10 | 4/19 | 0/0 | 1/2 | 1/10 | 2/19 | 30.2 ± 14.1 | IHC + FISH | |
| Lim et al. [6] | 0 | 1 | 8 | 12 | 0/0 | 1/1 | 3/8 | 2/12 | 0/0 | 1/1 | 0/8 | 2/12 | 43.4 ± 20.0 | FISH | |
| Plfueger et al. [17] | 3 | 2 | 5 | 12 | 1/3 | 0/2 | 0/5 | 3/12 | 1/3 | 0/2 | 1/5 | 0/12 | 24.6 ± 20.3 | IHC + FISH | |
| Song et al. [18] | 13 | 9 | 0 | 0 | – | – | – | – | – | – | – | – | – | IHC + FISH | |
| Pan et al. [19] | 1 | 0 | 3 | 9 | 0/1 | 0/0 | 0/3 | 4/9 | 0/1 | 0/0 | 0/3 | 4/9 | 24.9 ± 9.2 | IHC + FISH | |
| total | 20 | 17 | 72 | 118 | 1/7 | 3/8 | 9/55 | 25/97 | 1/7 | 2/8 | 10/55 | 18/97 | |||